Reason for study withdrawal, n (%) | H |
---|---|
N = 25 | |
AE/intercurrent illness | 1 (4.0) |
Insufficient therapeutic responsea | 6 (24.0) |
Switch to commercially available H treatment | 2 (8.0) |
Refusal of treatment | 1 (4.0) |
Other | 15 (60.0) |
Study completion/closure | 5 (20.0) |
Sponsor request | 4 (16.0) |
Investigator decision | 3 (12.0) |
Switch to H SC | 2 (8.0) |
Treatment discontinued until further disease progression | 1 (4.0) |